LH - Labcorp Holdings Inc Stock Analysis
Labcorp Holdings Inc (LH) is a publicly traded company listed on the NYSE. It operates in the Diagnostics & Research industry, part of the broader Healthcare sector. The company has a market capitalization of 21.68B, generates annual revenue of 13.77B, and reports net income of 855.20M. As of the latest data, the stock is trading at 261.48 USD.
From a valuation and risk perspective, the stock presents the following profile: The stock is moderately valued and aligns with market expectations for established companies. The PEG ratio is above 2, which could imply the stock is overvalued based on its growth outlook. The company maintains a healthy balance between debt and equity, which is typical for stable businesses. The dividend yield (1.12%) is modest, often associated with growth-oriented companies. The stock has average market volatility, aligning with general market movement.
Analyst recommendation stands at Buy (4.14), indicating current market sentiment. Institutional ownership is reported at 97.16%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of 8.66%, trading within a 52-week range of 209.38 - 293.72.
LH - Labcorp Holdings Inc
261.48
Analyst Consensus
Buy 4.14
LH – Analyst Rating Summary
- Strong Buy: 10
- Buy: 13
- Hold: 6
- Sell: 0
- Strong Sell: 0
- Total Analysts: 29
| Index: | S&P 500 | P/E: | 25.68 | EPS (ttm): | 10.18 | Insider Own: | 0.31% | Shs Outstand: | 83.00M | Perf Week: | -2.53% |
| Market Cap: | 21.68B | Forward P/E: | 14.92 | EPS next Y: | 17.52 | Insider Trans: | -11.84% | Shs Float: | 82.65M | Perf Month: | 3.63% |
| Income(ttm): | 855.20M | PEG: | 2.69 | EPS next Q: | 3.94 | Inst Own: | 97.16% | Short Float: | 3.89% | Perf Quarter: | -6.17% |
| Revenue(ttm): | 13.77B | P/S: | 1.57 | EPS this Y: | 12.08% | Inst Trans: | -2.73% | Short Ratio: | 4.25 | Perf Half Y: | 3.70% |
| Book/sh: | 104.78 | P/B: | 2.50 | EPS next Y: | 7.29% | ROA: | 4.64% | Short Interest: | 3.21M | Perf Year: | 8.66% |
| Cash/sh: | 7.21 | P/C: | 36.24 | EPS next 5Y: | 9.55% | ROE: | 10.14% | 52W Range: | 209.38 - 293.72 | Perf YTD: | 14.02% |
| Dividend Est.: | 2.93 (1.12%) | P/FCF: | 15.70 | EPS past 3/5Y: | -28.70% 1.13% | ROIC: | 5.88% | 52W High: | 293.72 -10.98% | Beta: | 0.99 |
| Dividend TTM: | 2.88 (1.10%) | Quick Ratio: | 1.35 | Sales past 3/5Y: | -6.90% 2.40% | Gross Margin: | 26.43% | 52W Low: | 209.38 24.89% | Perf 5Y: | 52.19% |
| Dividend Ex-Date: | Nov 26, 2025 | Current Ratio: | 1.55 | EPS Y/Y TTM: | 97.24% | Oper. Margin: | 9.92% | RSI (14): | 44.26 | Volatility: | 1.56% 2.20% |
| Employees: | 70000 | Debt/Eq: | 0.75 | Sales Y/Y TTM: | 8.28% | Profit Margin: | 6.21% | Recom: | 1.74 | Target Price: | 301.59 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 0.67 | EPS Q/Q: | 55.52% | Payout: | 32.58% | Rel Volume: | 1.14 | Prev Close: | 265.76 |
| Sales Surprise: | 0.16% | EPS Surprise: | 1.21% | Sales Q/Q: | 8.58% | Earnings: | Oct 28 BMO | Avg Volume: | 755.04K | Price: | 261.48 |
| SMA20: | -0.79% | SMA50: | -3.17% | SMA200: | 1.68% | Undervalued: 15.34% | Volume: | 861,158 | Change: | -1.61% | |
Graham Classic formula value: 252.3
(P/E=8 * 1g) Min value: 160.43
(current P/E * 2g) Max value: 409.34
Average value: 274.02
About Labcorp Holdings Inc
Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.